VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
10861
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1303
Interactions with Platform & by Email
PARTICIPANTS
326
Unique # Participated
VALIDATIONS
147
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
108
PAGES
180
EDITION
7
PRICE
USD $4950
With the Global Economy Walking the Tightrope, It's the Numbers that Help Understand this Uncertain World.
Amid the COVID-19 crisis, the global market for Ulcerative Colitis Therapeutics estimated at US$5.6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Ulcerative Proctitis, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Proctosigmoiditis segment is readjusted to a revised 5.4% CAGR for the next 7-year period.
The Ulcerative Colitis Therapeutics market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.
In the global Left-sided Colitis segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.4 Billion in the year 2020 will reach a projected size of US$2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$912.9 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 180-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Laboratories, Inc.; AbbVie, Inc.; Amgen, Inc.; Arena Pharmaceuticals, Inc.; Astellas Pharma, Inc.; AstraZeneca PLC; Avaxia Biologics, Inc.; BioLineRx Ltd.; Celgene Corporation; Cosmo Pharmaceuticals NV; EA Pharma Co., Ltd.; Eisai Co., Ltd.; Ferring Pharmaceuticals; Galapagos NV; Genentech, Inc.; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Hutchison MediPharma Limited; Immune Pharmaceuticals, Inc.; InDex Pharmaceuticals Holding AB; Janssen Biotech, Inc.; Kaken Pharmaceutical Co., Ltd.; Kissei Pharmaceutical Co., Ltd.; Kyowa Hakko Kirin Co., Ltd.; Lipid Therapeutics GmbH; Meda AB; Merck & Co., Inc.; Mitsubishi Tanabe Pharma Corporation; Mochida Pharmaceutical Co., Ltd.; Morphotek, Inc.; Nestle SA; Pfizer, Inc.; Procter & Gamble Company, The; Qu Biologics Inc.; Salix Pharmaceuticals, Inc.; Shield Therapeutics PLC; Shire Pharmaceuticals, Inc.; Sterna Biologicals GmbH & Co. KG; Takeda Pharmaceuticals Company Ltd.; Tillotts Pharma AG; TopiVert Ltd.; UCB SA; Zeria Pharmaceutical Co., Ltd.
» Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis) » Route of Administration (Oral, Injectables)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Ulcerative Colitis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Ulcerative Colitis Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Ulcerative Colitis Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Ulcerative Colitis Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Ulcerative Proctitis (Disease Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Ulcerative Proctitis (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Ulcerative Proctitis (Disease Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Proctosigmoiditis (Disease Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Proctosigmoiditis (Disease Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Proctosigmoiditis (Disease Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Left-sided Colitis (Disease Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Left-sided Colitis (Disease Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Left-sided Colitis (Disease Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Pancolitis or Universal Colitis (Disease Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
| Pancolitis or Universal Colitis (Disease Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Pancolitis or Universal Colitis (Disease Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Fulminant Colitis (Disease Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Fulminant Colitis (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Fulminant Colitis (Disease Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Oral (Route of Administration) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 |
| Oral (Route of Administration) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Oral (Route of Administration) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
| Injectables (Route of Administration) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025 |
| Injectables (Route of Administration) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017 |
| Injectables (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Ulcerative Colitis Market Share (in %) by Company: 2019 & 2025 |
| United States Ulcerative Colitis Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025 |
| Ulcerative Colitis Market in the United States by Disease Type: A Historic Review in US$ Million for 2009-2017 |
| United States Ulcerative Colitis Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 |
| United States Ulcerative Colitis Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025 |
| Ulcerative Colitis Market in the United States by Route of Administration: A Historic Review in US$ Million for 2009-2017 |
| United States Ulcerative Colitis Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025 |
| Canadian Ulcerative Colitis Historic Market Review by Disease Type in US$ Million: 2009-2017 |
| Ulcerative Colitis Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025 |
| Canadian Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 |
| Canadian Ulcerative Colitis Historic Market Review by Route of Administration in US$ Million: 2009-2017 |
| Ulcerative Colitis Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 |
| JAPAN |
| Japanese Market for Ulcerative Colitis: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025 |
| Ulcerative Colitis Market in Japan: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017 |
| Japanese Ulcerative Colitis Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 |
| Japanese Market for Ulcerative Colitis: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025 |
| Ulcerative Colitis Market in Japan: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 |
| Japanese Ulcerative Colitis Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Ulcerative Colitis Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025 |
| Ulcerative Colitis Historic Market Analysis in China in US$ Million by Disease Type: 2009-2017 |
| Chinese Ulcerative Colitis Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Ulcerative Colitis Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 |
| Ulcerative Colitis Historic Market Analysis in China in US$ Million by Route of Administration: 2009-2017 |
| Chinese Ulcerative Colitis Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Ulcerative Colitis Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Ulcerative Colitis Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Ulcerative Colitis Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Ulcerative Colitis Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025 |
| Ulcerative Colitis Market in Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017 |
| European Ulcerative Colitis Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 |
| European Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 |
| Ulcerative Colitis Market in Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 |
| European Ulcerative Colitis Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| FRANCE |
| Ulcerative Colitis Market in France by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Ulcerative Colitis Historic Market Scenario in US$ Million by Disease Type: 2009-2017 |
| French Ulcerative Colitis Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 |
| Ulcerative Colitis Market in France by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Ulcerative Colitis Historic Market Scenario in US$ Million by Route of Administration: 2009-2017 |
| French Ulcerative Colitis Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| GERMANY |
| Ulcerative Colitis Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025 |
| German Ulcerative Colitis Historic Market Analysis in US$ Million by Disease Type: 2009-2017 |
| German Ulcerative Colitis Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 |
| Ulcerative Colitis Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025 |
| German Ulcerative Colitis Historic Market Analysis in US$ Million by Route of Administration: 2009-2017 |
| German Ulcerative Colitis Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Ulcerative Colitis Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025 |
| Ulcerative Colitis Historic Market Analysis in Italy in US$ Million by Disease Type: 2009-2017 |
| Italian Ulcerative Colitis Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Ulcerative Colitis Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025 |
| Ulcerative Colitis Historic Market Analysis in Italy in US$ Million by Route of Administration: 2009-2017 |
| Italian Ulcerative Colitis Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Market for Ulcerative Colitis: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025 |
| Ulcerative Colitis Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017 |
| United Kingdom Ulcerative Colitis Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Ulcerative Colitis: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025 |
| Ulcerative Colitis Market in the United Kingdom: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017 |
| United Kingdom Ulcerative Colitis Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025 |
| Ulcerative Colitis Market in Rest of Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Ulcerative Colitis Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025 |
| Rest of Europe Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025 |
| Ulcerative Colitis Market in Rest of Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017 |
| Rest of Europe Ulcerative Colitis Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Ulcerative Colitis Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Ulcerative Colitis Historic Market Scenario in US$ Million by Disease Type: 2009-2017 |
| Asia-Pacific Ulcerative Colitis Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025 |
| Ulcerative Colitis Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Ulcerative Colitis Historic Market Scenario in US$ Million by Route of Administration: 2009-2017 |
| Asia-Pacific Ulcerative Colitis Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025 |
| REST OF WORLD |
| Rest of World Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025 |
| Rest of World Ulcerative Colitis Historic Market Review by Disease Type in US$ Million: 2009-2017 |
| Ulcerative Colitis Market in Rest of World: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025 |
| Rest of World Ulcerative Colitis Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025 |
| Rest of World Ulcerative Colitis Historic Market Review by Route of Administration in US$ Million: 2009-2017 |
| Ulcerative Colitis Market in Rest of World: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 42 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com